(2023)
Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE.
BLOOD ADVANCES.
7,
17
(2023)
Biosimilars in rare diseases: a focus on paroxysmal nocturnal hemoglobinuria.
HAEMATOLOGICA.
108,
5
(2022)
Effects of CALR-Mutant Type and Burden on the Phenotype of Myeloproliferative Neoplasms.
DIAGNOSTICS.
12,
11
(2022)
Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study.
BLOOD ADVANCES.
-,
-
(2022)
Management of immune thrombocytopenia: 2022 update of Korean experts recommendations.
Blood Res.
57,
1
(2021)
Association between body image dissatisfaction and poor quality of life and depression among patients with hematopoietic stem cell transplantation.
SUPPORTIVE CARE IN CANCER.
-,
-
(2021)
Mutations in genes affecting DNA methylation enhances responses to decitabine in patients with myelodysplastic syndrome.
KOREAN JOURNAL OF INTERNAL MEDICINE.
36,
2
(2021)
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
BRITISH JOURNAL OF HAEMATOLOGY.
192,
1
(2021)
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study.
JOURNAL OF CLINICAL ONCOLOGY.
39,
1
(2020)
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
NEW ENGLAND JOURNAL OF MEDICINE.
383,
26
(2020)
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.
NEW ENGLAND JOURNAL OF MEDICINE.
383,
7
(2020)
Getting patient blood management Pillar 1 right in the Asia-Pacific: a call for action.
SINGAPORE MEDICAL JOURNAL.
61,
6
(2020)
Efficacy of intravenous iron treatment for chemotherapy-induced anemia: A prospective Phase II pilot clinical trial in South Korea.
PLOS MEDICINE.
17,
6
(2020)
Relationship of Circulating Cytomegalovirus Levels Obtained Through Antigenemia Testing and Quantitative PCR Differs Between Children and Adults.
ANNALS OF LABORATORY MEDICINE.
40,
1
(2020)
Relationship of Circulating Cytomegalovirus Levels Obtained Through Antigenemia Testing and Quantitative PCR Differs Between Children and Adults..
ANNALS OF LABORATORY MEDICINE.
40,
1
(2019)
Anti-leukemic effects of simvastatin on NRAS(G12D) mutant acute myeloid leukemia cells.
MOLECULAR BIOLOGY REPORTS.
46,
6
(2019)
Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial.
LANCET HAEMATOLOGY.
6,
11
(2019)
Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA.
19,
10
(2019)
Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis.
ANNALS OF HEMATOLOGY.
98,
10
(2019)
Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria.
INTERNATIONAL JOURNAL OF HEMATOLOGY.
110,
4
학술회의논문
(2009)
Decitabine Activity in Myelodysplastic Syndromes International Coopera-tive Multi Center Study.
BLOOD.
미국
(2009)
Effectiveness of Decitabine Chronic Myelomonocytic
Leukemia Patients International Cooperative Nulti-Center Study.
BLOOD.
미국
(2009)
Monosomy Karyotype in Acute Myeloid Leukemia Predicts Adverse Treatment Outcome with Low Complete Remission Rate and Worse Event-Free
and Overall Survival and Associates with High Functional Acivity of Multidrung Resistance..
BLOOD.
미국
(2009)
candidate Pathway Approach of Singe Nucleotide polymorphism On Imatininab Transport/Metabolism Pathway and DNA Repair Enzyme Pathway
Associated with Response and Resistanse to Imatinib Therapy in Chronic Myeloid Leukemia.
BLOOD.
미국
(2009)
comprehensive Evaluation of Time-To-Response Parameter as a Predictor of Long-Term Outcomes Following Imatinib Therapy in Chronic Phase Chronic Myeloid Leukemia.
BLOOd.
미국
(2009)
No impact of PML/RARa isoform subtype on clinical outcomes following Idarubicin/all-trans-retinoic.
5TH INTERNATIONAL SYMPOSIUM ON.
이탈리아
(2009)
Non-Hodgkin lymphoma of rare extranodal sites: Are they different from commonly involved sites?.
제50차 대한혈액학회 춘계학술대회.
대한민국
(2009)
The use of intravenous busulfan combined with cyclophosphamide (ivBuCy)reduces early hepatic toxicity and non-relaps mortality and non-relapse mortality following allogeneic hematopoietic stem cell transplantation compared to oral busulfan containing regimen(poBuCy).
EBMTR.
미국
(2009)
Multicenter Retrospective Analysis of Second Allogeneic HSCT Outcomes for Hematologic Malignancies in Korea:Interim analysis.
대한조혈모세포이식학회.
대한민국
(2009)
Vascular endothelial growth factor(VEGFA)gene polymorphisms may predict the risk bof acute GVHD.
ASBMT.
대한민국
